Growing community of inventors

Piscataway, NJ, United States of America

Stuart W Peltz

Average Co-Inventor Count = 3.68

ph-index = 2

The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.

Forward Citations = 5

Stuart W PeltzKevin Czaplinski (5 patents)Stuart W PeltzJoseph P Dougherty (2 patents)Stuart W PeltzHolger Beckmann (2 patents)Stuart W PeltzYacov Ron (2 patents)Stuart W PeltzJonathan D Dinman (2 patents)Stuart W PeltzSofiya Micheva-Viteva (2 patents)Stuart W PeltzAnnmarie Pacchia (2 patents)Stuart W PeltzMarc Learned (2 patents)Stuart W PeltzYoumin Weng (1 patent)Stuart W PeltzAnnmarie L Pacchia (0 patent)Stuart W PeltzStuart W Peltz (7 patents)Kevin CzaplinskiKevin Czaplinski (5 patents)Joseph P DoughertyJoseph P Dougherty (8 patents)Holger BeckmannHolger Beckmann (7 patents)Yacov RonYacov Ron (7 patents)Jonathan D DinmanJonathan D Dinman (3 patents)Sofiya Micheva-VitevaSofiya Micheva-Viteva (2 patents)Annmarie PacchiaAnnmarie Pacchia (2 patents)Marc LearnedMarc Learned (2 patents)Youmin WengYoumin Weng (1 patent)Annmarie L PacchiaAnnmarie L Pacchia (0 patent)
..
Inventor’s number of patents
..
Strength of working relationships

Company Filing History:

1. University of Medicine and Dentistry of New Jersey (4 from 272 patents)

2. Other (2 from 832,966 patents)

3. Ptc Therapeutics, Inc. (1 from 184 patents)


7 patents:

1. 9017935 - HIV-1 latency model for high throughput screening

2. 8247167 - HIV-1 latency model for high throughput screening

3. 7026122 - Methods of assaying for compounds that inhibit premature translation termination and nonsense-mediated RNA decay

4. 6989256 - Subfamily of RNA helicases which are modulators of the fidelity of translation termination and uses thereof

5. 6630294 - Subfamily of RNA helicases which are modulators of the fidelity of translation termination and uses thereof

6. 6486305 - METHOD OF MODULATING THE EFFICIENCY OF TRANSLATION TERMINATION AND DEGRADATION OF ABERRANT MRNA INVOLVING A SURVEILLANCE COMPLEX COMPRISING HUMAN UPF1P, EUCARYOTIC RELEASE FACTOR 1 AND EUCARYOTIC RELEASE FACTOR 3

7. 6458538 - Methods of assaying for compounds that inhibit premature translation termination and nonsense-mediated RNA decay

Please report any incorrect information to support@idiyas.com
idiyas.com
as of
1/19/2026
Loading…